Navigation Links
Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc.
Date:11/9/2007

Sonomed to Showcase Product Portfolio at the American Academy of

Ophthalmology Annual Meeting

WAYNE, Pa., Nov. 9 /PRNewswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq Capital Market: ESMC) today announced the promotion of Mr. Barry Durante to President of Sonomed, a wholly-owned subsidiary of Escalon and a worldwide leader in ophthalmic ultrasound. In his new role he will be responsible for Sonomed's entire operations, while leading the company's technology and product development strategies. Mr. Durante joined Sonomed in 1988 and has served in numerous management positions, most recently as Executive Vice President.

Richard J. DePiano Jr., Escalon's Chief Operating Officer, commented, "Barry has played an important role in Sonomed's growth and development and we believe this is a natural transition. Over the past two decades he has been successful in growing sales on a consistent basis while exceeding customer expectations. His vast experience in dealing with both domestic and international distribution networks will be most beneficial as we continue to implement targeted growth strategies."

Sonomed will showcase its industry-leading product portfolio at the American Academy of Ophthalmology Annual Meeting, November 10 - 13, 2007, in New Orleans, LA. Sonomed develops, manufactures and markets ultrasound systems for diagnostic and biometric applications in ophthalmology. The systems are of four types: A-Scans, B-Scans, High Frequency B-Scans ("UBMs") and pachymeters.

Prior to joining Sonomed, Mr. Durante was with Sonometrics Incorporated, an ophthalmic ultrasound manufacturer and Ocusery, Inc., an ophthalmic mobile services company.

Founded in 1987, Escalon develops markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. Drew, which operates as a separate business unit, provides instrumentation and consumables for the diagnosis and moni
'/>"/>

SOURCE Escalon Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...JERUSALEM, Israel, December 2 Gami...ting the preclinical (animal study) safety and,eff...hnology from Weill,Cornell Medical College and Gam...inherited anemias such as Cooley,s Anemia. , ...gies to expand, ex vivo,populations of stem/proge...
(Date:12/2/2009)...ON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Eme...) (OTC Bulletin Board: EMDY), a leading,producer a...ilk powder and,soybean products in China, today an...pring issue of US Food & Drink Executive, a qu... executives in the food and beverage industry. ,...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris...a global biopharmaceutical company focused on endo...he U.S. Food and Drug Administration (FDA) has gra.../Akt pathway inhibitor compound, perifosine (KRX-0...tiple myeloma. Keryx Biopharmaceuticals, Inc. ("Ke...
(Date:12/2/2009)... The Scientist, a leading scientific magazine co...o; Evolve “Intelligent” EMCCD camera f...Innovations of 2009. , (P...D camera from Photometrics ®, a designer and...meras for the life sciences, was ranked fourth amo...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...nc. (Amex: ANX ) announced today that Eric K. Row...ice President of ImClone Systems Incorporated, wil...Dr. Rowinsky,s appointment,ADVENTRX increased the ...We are delighted to welcome Eric to our Board of D...tise within the oncology field," stated Evan,M. Le...
...edings of the National Academy of Sciences (PNAS) ...nd Graziano Vernizzi from Northwestern Universitys...he prestigious 2007 Cozzarelli Prize. , Olvera de... of materials science and engineering in the McCor... director of the Materials Research Center; Verniz...
...rated (Nasdaq: GNTA ) today announced that Richar...ial Officer, has indicated his intention to,retire...n Mr. Moran,s,retirement, Gary Siegel, currently V... Principal Accounting Officer and Principal Financ... the past 5 years in financial roles,of increasing...
Other Biology Technology:Eric K. Rowinsky Joins ADVENTRX Board of Directors 2Eric K. Rowinsky Joins ADVENTRX Board of Directors 3Eric K. Rowinsky Joins ADVENTRX Board of Directors 4PNAS paper and its authors honored for scientific excellence 2Genta Announces Senior Management Changes 2Genta Announces Senior Management Changes 3Genta Announces Senior Management Changes 4
(Date:12/1/2009)...heimer,s disease, nerve cell degeneration plays a ...ns may possibly be derived from steering the gener...ave been published in the current issue of the ren...few years ago, neurogenesis the process of nerve ...in the adult brain. The textbooks asserted that de...
(Date:12/1/2009)...inner of the 2009 Inserm Grand Prix., Every year... paying tribute to outstanding,work performed in ...ents, Inserm intends to,demonstrate the diversity...ogical, medical and,health research, and the crea...out and,drive this research each day. The Inserm ...
(Date:12/1/2009)... Monash University-led international research team...ut of the next generation of solar cells. , Scie... colleagues from the universities of Wollongong an...sed solar cells with a three-fold increase in ener...reported tandem dye-sensitised solar cells. , L...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Innovation puts next-generation solar cells on the horizon 2Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 1Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 2Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 3Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 4Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 5BioSpace Launches the 2009 2010 Biotech Bay Hotbed Campaign 55661 1BioSpace Launches the 2009 2010 Biotech Bay Hotbed Campaign 55661 2Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 1Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 2Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 3
... Pseudomonas aeruginosa is a bacterium that can ca...e threatening in patients who have cystic fibrosis...gainst this pathogen. Appearing online on 1 April ...sue of The Journal of Clinical Investigation, Rona...use a novel strategy to create a genetic vaccine a...
... The brains of one species of mouse actually shrin... difficulty with some types of learning, a new stu...hort days of winter, white-footed mice had impaire...emember important places in their environment. , T...hanges in the structure and the functioning of bra...
... Investigators from the University California, San...ancer Research (LICR) and NimbleGen Systems have d... of regulatory sequences in the human genome, acco...s are defined by their ability to generate a funct...e that controls when and where a gene product is g...
Other Biology News:Mice brains shrink during winter, impairing some learning and memory 2Mice brains shrink during winter, impairing some learning and memory 3Whole genome promoter mapping - Human Genome Project v2.0? 2
...ws a rapid and efficient immunoprecipitation and e...oprecipitation is performed with ANTI-FLAG-M2 affi...tibody covalently attached to agarose resin. The u...f FLAG-tagged proteins without the need for prelim...
Benchtop Laminar Flow Hood (Environmental Control Module) from Terra Universal, Inc.
Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.
Innova 4900 Multi-Shaker Environmental Chamber, Holds up to 4 Shakers from New Brunswick Scientific Co., Inc.
Biology Products: